With an increasing number of people suffering anterior cruciate ligament (ACL) injuries, researchers at the Kolling Institute say a broader range of tendon grafts could be successfully adopted by surgeons undertaking knee reconstructions. The research, which is the second-largest human tendon study ever published, is prompting calls for tissue banks to review current age restrictions and.....
Read more

Arthritis is the third most prevalent long-term health condition in Australia affecting more than 12 per cent of Australians. There is no cure for arthritis, with treatment options largely focused on alleviating pain, including pain relief medication, arthroscopy or joint replacement. Australia is at the forefront of clinical research and trials, which is helping the community better man.....
Read more

We would like to congratulate Professor Chris Little who has received a highly coveted award for his outstanding commitment to orthopaedic research. Professor Little has been elected a Fellow of International Orthopaedic Research at a key international conference in Edinburgh Scotland. The award is only presented every three years, with around 20 people across the globe receiving the acc.....
Read more

A $400,000 robot which may hold the key to significant improvements in hip and knee replacements is now operational at the Kolling Institute. Known as KOBRA or the Kolling Orthopaedic Biomechanics Robotic Arm, the new technology delivers an advanced testing facility, while greatly increasing research capabilities. It is the largest of its kind in Australia and one of just two SimVitro ro.....
Read more

Kolling Institute researchers have helped map out exciting future developments for the rehabilitation of hip and knee replacement patients. A team of researchers from Sydney Musculoskeletal Health – a partnership between the University of Sydney, Sydney Local Health District and Northern Sydney Local Health District - recently attended the International Society for Technology in Arthropl.....
Read more

Our researchers are seeking participants for a large-scale clinical trial pioneering the use of stem cells to treat and potentially cure osteoarthritis. The disease is now one of the leading causes of disability in the world, affecting around three million people in Australia alone. Royal North Shore Hospital rheumatologist Professor David Hunter is leading the two-year trial which is re.....
Read more

The largest study in Australia into the treatment of juvenile arthritis may pave the way for a unique approach to care for those with the disabling condition and dramatically improve outcomes. The Medical Research Future Fund will invest $2.5 million in the A3BC for Kids project which will involve researchers from the Kolling Institute and the University of Sydney in collaboration with t.....
Read more

New research by a team from the Kolling Institute has found the best treatment for chronic low back pain doesn’t just focus on the physical, but combines physiotherapy treatments with those focusing on the mind. The study, involving Emma Ho, Professor Manuela Ferreira and Lingxiao Chen, analysed evidence from almost 100 trials worldwide involving over 13,000 patients. It found a combinat.....
Read more

Congratulations to Kolling Institute researcher Dr Manasi Mittinty who has been selected for the Advanced Global Clinical Scholar Research training at Harvard Medical School. Dr Mittinty is a medical trained researcher with the Pain Management and Research Centre and a University of Sydney lecturer. She has a keen interest in translation research and the connections between musculoskelet.....
Read more

Research conducted by a team from Kolling Institute has found that swallowing difficulties after a whiplash injury appear to be an under-recognised consequence of the injury. The study investigated a group of 60 patients with low-grade whiplash, finding 50 per cent of patients reported swallowing problems within 12 months of their whiplash injury. In 31 of these patients, there was a sta.....
Read more